{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:54:52Z","timestamp":1788893692642,"version":"build-2803163510"},"reference-count":14,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"vor","delay-in-days":6187,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this double\u2010blind, placebo\u2010controlled study was to evaluate in males the clinical efficacy in treating molluscum contagiosum and tolerance of an analog of imiquimod (1%) in cream. One hundred patients between 9 and 27 years of age (mean 16.3), with 733 lesions (mean 7.3), whose size ranged from 2 to 5 mm diameter (mean spot size 3.4 mm) and a biopsy\u2010confirmed diagnosis of molluscum contagiosum were randomized into two parallel groups. In a double\u2010blind manner, precoded 40\u2010g tubes were dispensed. Patients self\u2010administered the trial medication to their lesions at home three times daily for five consecutive days per week. The study was scheduled with 4 weeks of active treatment (maximum 60 topical applications) and 12 months (on a monthly basis) of follow\u2010up. Patients were examined on a weekly basis. Thirteen patients had atopic dermatitis. A clinically and histopathologically confirmed total elimination of lesions was considered as cured. After four weeks of treatment, 49 patients and 372 lesions were cured. Breaking the code revealed that imiquimod cream had cured 82% of the patients and 86.3% of the lesions. Placebo cleared 16% of the patients and 63 of the lesions (p&lt;0.0001). During the treatment, 88% of the patients experienced no allergic, localized, or drug\u2010related adverse symptoms. Twelve patients, predominantly in the imiquimod cream group reported non\u2010objective, drug\u2010induced, mild reactions with no dropouts. The study was followed\u2010up for 12 months. Among 49 cured patients, 3 had relapses after 10 months. In conclusion, the study demonstrated that 1% imiquimod analog in cream with mild subjective side effects is significantly more efficacious than the placebo in curing molluscum contagiosum in males.<\/jats:p>","DOI":"10.1111\/j.1346-8138.1998.tb02403.x","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T08:08:36Z","timestamp":1428653316000},"page":"309-313","source":"Crossref","is-referenced-by-count":76,"title":["Treatment of Molluscum Contagiosum in Males with an Analog of Imiquimod 1% in Cream: A Placebo\u2010Controlled, Double\u2010Blind Study"],"prefix":"10.1111","volume":"25","author":[{"given":"Tanweer A.","family":"Syed","sequence":"first","affiliation":[{"name":"Department of Dermatology University of California San Francisco  U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Goswami","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California San Francisco  U.S.A."},{"name":"Urmi Clinic  Baroda Gujarat India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver Abbas","family":"Ahmadpour","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California San Francisco  U.S.A."},{"name":"University of Ume\u00e5  Ume\u00e5 Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California San Francisco  U.S.A."},{"name":"Windsor High School  Windsor CA 95492 U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1996.tb03270.x"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199612)50:4<342::AID-JMV10>3.0.CO;2-K"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00370727"},{"key":"e_1_2_1_5_1","first-page":"394","article-title":"Keloid scars as a result of carbon dioxide laser for molluscum contagiosum","volume":"70","author":"Friedman M","year":"1987","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000246787"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546639109092730"},{"key":"e_1_2_1_8_1","first-page":"5176","article-title":"Phase I trial of an oral immunomodulator and interferon inducer in cancer patients","volume":"53","author":"Witt PL","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70441-1"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/095646249500600604"},{"key":"e_1_2_1_11_1","unstructured":"SyedTA AhmadpourOA AhmadSA AhmadSH:Management of genital warts in women with an analog of imiquimod 2% in cream: A randomized double\u2010blind placebo\u2010controlled study J Dermatol (in press)"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0890-8508(92)90073-7"},{"key":"e_1_2_1_13_1","first-page":"s127","article-title":"Induction of antiviral activity and cytokines by oral imiquimod in healthy volunteers","volume":"12","author":"Imbertson LM","year":"1992","journal-title":"J Interferon Res"},{"key":"e_1_2_1_14_1","first-page":"405","volume-title":"Cutaneous Infection and Therapy","author":"Tomai MA","year":"1997"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.4.2207"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.1998.tb02403.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.1998.tb02403.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T09:05:00Z","timestamp":1698483900000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.1998.tb02403.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1111\/j.1346-8138.1998.tb02403.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.1998.tb02403.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}